WEST LAFAYETTE, Ind., May 1, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company has rescheduled the call of its first quarter 2014 financial results and business update to Friday, May 2, at 8:30 a.m. EDT.
Help employers find you! Check out all the jobs and post your resume.
